Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst

Published on 19 Nov 2024 on Benzinga · via Yahoo Finance

On Monday, Silence Therapeutics plc (NASDAQ:SLN) presented end-of-treatment data from its Phase 2...

Read the rest of the article

Start tracking your investments with Statfolio

Investors are anxious about the impact of the incoming administration of President-elect Donald T...

Los Angeles Business Journal 25 Nov 2024

Explore our interactive list of high quality stocks to get an idea of what else is out there you ...

Simply Wall St. · via Yahoo Finance 24 Nov 2024

United States shares mixed at close of trade; Dow Jones Industrial Average up 0.32%

Investing.com 20 Nov 2024

On Monday, Silence Therapeutics plc (NASDAQ:SLN) presented end-of-treatment data from its Phase 2...

Benzinga · via Yahoo Finance 19 Nov 2024

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Nov 2024

Kennedy Jr., a prominent vaccine skeptic, as the Head of the Department of Health and Human Servi...

Zacks · via Yahoo Finance 18 Nov 2024

Because of this, empirical studies indicate a strong correlation between trends in earnings estim...

Zacks · via Yahoo Finance 18 Nov 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.70%

Investing.com 16 Nov 2024

Here's what Jim had to say about the whole group. Pepsico : After reporting a bad third quarter w...

CNBC 15 Nov 2024

(Bloomberg) -- Health stocks slumped on Friday as Wall Street weighed the impact that prominent...

Bloomberg · via Yahoo Finance 15 Nov 2024